[
    [
        {
            "time": "",
            "original_text": "港股IPO|沃森生物向证监会提交境外审批材料，拟香港上市",
            "features": {
                "keywords": [
                    "港股IPO",
                    "沃森生物",
                    "证监会",
                    "境外审批",
                    "香港上市"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "港股IPO|沃森生物向证监会提交境外审批材料，拟香港上市",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "国盛证券：疫苗整体批签发稳定增长 龙头品种态势良好",
            "features": {
                "keywords": [
                    "国盛证券",
                    "疫苗",
                    "批签发",
                    "稳定增长",
                    "龙头品种"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国盛证券：疫苗整体批签发稳定增长 龙头品种态势良好",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【朝闻国盛0202】疫苗整体批签发稳定增长，二类苗增长明显，龙头品种态势良好",
            "features": {
                "keywords": [
                    "朝闻国盛",
                    "疫苗",
                    "批签发",
                    "稳定增长",
                    "二类苗",
                    "龙头品种"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【朝闻国盛0202】疫苗整体批签发稳定增长，二类苗增长明显，龙头品种态势良好",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]